| Announce Date | 10/28/2025 | 
| EPS Normalized Actual | $2.61 (Beat by $0.21) | 
| EPS GAAP Actual | $2.61 (Beat by $0.21) | 
| Revenue Actual | $2.444B | 
| Revenue Surprise | Beat by $2444M | 
| Announce Date | 12/31/1969 (Pre-Market) | 
| EPS Normalized Estimate | $ | 
| EPS GAAP Estimate | $ | 
| Revenue Estimate | $0B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Jun 2030 | 21.5433 | 11.88 | 19.56504 | 23.13726 | 1 | 
| Jun 2030 | 21.5433 | 11.88 | 20.04015 | 22.69654 | 1 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 2.3 | 2.3 | 2.444B | 22.79% | 2444M | 
| FQ1 2025 (Mar 2025) | 1.62 | 1.62 | 2.16B | 23.38% | 2160M | 
| FQ4 2024 (Dec 2024) | -1.45 | -1.45 | 2.325B | 33.12% | 2325M | 
| FQ3 2024 (Sep 2024) | 1.45 | 1.45 | 2.168B | 32.93% | 2168M | 
| FQ2 2024 (Jun 2024) | 2.44 | 2.44 | 1.887B | 15.1% | 1887M | 
| FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 1.655B | -12.39% | 1655M | 
| FQ4 2023 (Dec 2023) | -0.0909 | -0.0909 | 1.555B | -21.35% | 1555M | 
| FQ3 2023 (Sep 2023) | -0.88 | -0.88 | 1.454B | -39.96% | 1454M | 
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 2.36846 | -- | 2.27785 | 2.46485 | 6 | 
| FQ1 2028 (Mar 2028) | 2.36858 | -- | 2.33055 | 2.45828 | 10 | 
| FQ4 2027 (Dec 2027) | 2.45346 | -- | 2.41407 | 2.54637 | 9 | 
| FQ3 2027 (Sep 2027) | 2.42471 | -- | 2.38578 | 2.51653 | 9 | 
| FQ2 2027 (Jun 2027) | 2.72228 | -- | 2.63575 | 2.90322 | 11 | 
| FQ1 2027 (Mar 2027) | 2.57254 | -- | 2.49077 | 2.74353 | 10 | 
| FQ4 2026 (Dec 2026) | 2.37895 | -- | 2.26717 | 2.47623 | 5 | 
| FQ3 2026 (Sep 2026) | 3.02418 | -- | 2.90849 | 3.14726 | 9 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 2.5B | -- | 2.42B | 2.58B | 6 | 
| FQ1 2028 (Mar 2028) | 2.51B | -- | 2.48B | 2.58B | 14 | 
| FQ4 2027 (Dec 2027) | 2.47B | -- | 2.44B | 2.54B | 9 | 
| FQ3 2027 (Sep 2027) | 2.44B | -- | 2.41B | 2.51B | 11 | 
| FQ2 2027 (Jun 2027) | 2.37B | -- | 2.31B | 2.49B | 5 | 
| FQ1 2027 (Mar 2027) | 2.33B | -- | 2.27B | 2.45B | 10 | 
| FQ4 2026 (Dec 2026) | 2.63B | -- | 2.54B | 2.72B | 7 | 
| FQ3 2026 (Sep 2026) | 2.81B | -- | 2.72B | 2.89B | 8 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 2.3 | 2.3 | 100% | |
| FQ1 2025 (Mar 2025) | 1.62 | 1.62 | 100% | |
| FQ4 2024 (Dec 2024) | -1.45 | -1.45 | 100% | |
| FQ3 2024 (Sep 2024) | 1.45 | 1.45 | 100% | |
| FQ2 2024 (Jun 2024) | 2.44 | 2.44 | 100% | |
| FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0909 | -0.0909 | 100% | |
| FQ3 2023 (Sep 2023) | -0.88 | -0.88 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $2.44B | $2444M | 100% | 
| FQ1 2025 (Mar 2025) | $0B | $2.16B | $2160M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $2.33B | $2325M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $2.17B | $2168M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $1.89B | $1887M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $1.66B | $1655M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $1.56B | $1555M | 100% | 
| FQ3 2023 (Sep 2023) | $0B | $1.45B | $1454M | 100% |